Is this page useful for you? Then, help us to keep the service working. Please have a look to our donations page ... Thanks for your help!!

Drug Safety / Springer

Citation Profile [Updated: 2023-11-03 08:28:08]
5 Years H Index
6
Impact Factor (IF)
0.08
5 Years IF
0.07
Data available in this report

[Raw data] [50 most cited papers] [50 most relevant papers] [cites used to compute IF] [Recent citations ][Frequent citing series ] [more data in EconPapers] [trace new citations] [Missing citations? Add them now] [Incorrect content? Let us know]

Main indicators
Raw Data

 

IF AIF CIF IF5 DOC CDO CIT NCI CCU D2Y C2Y D5Y C5Y SC %SC CiY II AII
2012 0 0.52 0 0 7 7 0 0 0 0 0 0 0.22
2014 0 0.55 0 0 8 15 11 0 7 7 0 0 0.23
2015 0 0.55 0 0 1 16 0 0 8 15 0 0 0.23
2016 0.22 0.53 0.11 0.13 98 114 79 12 12 9 2 16 2 11 91.7 10 0.1 0.21
2017 0.15 0.54 0.15 0.16 119 233 79 34 46 99 15 114 18 30 88.2 11 0.09 0.22
2018 0.14 0.56 0.16 0.14 134 367 73 60 106 217 30 226 31 52 86.7 22 0.16 0.24
2019 0.09 0.58 0.15 0.07 131 498 55 76 182 253 22 360 26 68 89.5 33 0.25 0.23
2020 0.11 0.7 0.12 0.09 130 628 38 74 256 265 29 483 45 51 68.9 10 0.08 0.33
2021 0.08 0.87 0.1 0.07 124 752 22 78 334 261 22 612 45 48 61.5 9 0.07 0.32
2022 0.08 1 0.1 0.07 118 870 10 91 425 254 21 638 42 49 53.8 3 0.03 0.31
IF: Two years Impact Factor: C2Y / D2Y
AIF: Average Impact Factor for all series in RePEc in year y
CIF: Cumulative impact factor
IF5: Five years Impact Factor: C5Y / D5Y
DOC: Number of documents published in year y
CDO: Cumulative number of documents published until year y
CIT: Number of citations to papers published in year y
NCI: Number of citations in year y
CCU: Cumulative number of citations to papers published until year y
D2Y: Number of articles published in y-1 plus y-2
C2Y: Cites in y to articles published in y-1 plus y-2
D5Y: Number of articles published in y-1 until y-5
C5Y: Cites in y to articles published in y-1 until y-5
SC: selft citations in y to articles published in y-1 plus y-2
%SC: Percentage of selft citations in y to articles published in y-1 plus y-2
CiY: Cites in year y to documents published in year y
II: Immediacy Index: CiY / Documents.
AII: Average Immediacy Index for series in RePEc in year y
50 most cited documents in this series
#YearTitleCited
12018Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre. (2018). Hunsel, Florence ; Star, Kristina ; Zekarias, Alem ; Grundmark, Birgitta ; Harmark, Linda ; Taavola, Henric ; Chandler, Rebecca E ; Watson, Sarah. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:2:d:10.1007_s40264-017-0594-2.

Full description at Econpapers || Download paper

7
22014Text Mining for Adverse Drug Events: the Promise, Challenges, and State of the Art. (2014). Tamang, Suzanne ; Finlayson, Sam ; Harpaz, Rave ; LePendu, Paea ; Shah, Nigam ; Jung, Kenneth ; Odgers, David ; Callahan, Alison ; Low, Yen . In: Drug Safety. RePEc:spr:drugsa:v:37:y:2014:i:10:p:777-790.

Full description at Econpapers || Download paper

7
32017Evaluation of Facebook and Twitter Monitoring to Detect Safety Signals for Medical Products: An Analysis of Recent FDA Safety Alerts. (2017). Brownstein, John S ; Freifeld, Clark C ; Le, Hoa ; Rodriguez, Harold W ; Proestel, Scott ; Pamer, Carol ; Bouri, Khaled ; Pierce, Carrie E ; Dasgupta, Nabarun ; Edwards, Ralph I ; Walderhaug, Mark. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:4:d:10.1007_s40264-016-0491-0.

Full description at Econpapers || Download paper

7
42017Natural Language Processing for EHR-Based Pharmacovigilance: A Structured Review. (2017). Starren, Justin ; Carson, Matthew B ; Jonnalagadda, Siddhartha R ; Berendsen, Mark A ; Zeng, Zexian ; Herr, Timothy M ; Thompson, William K ; Luo, Yuan. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:11:d:10.1007_s40264-017-0558-6.

Full description at Econpapers || Download paper

7
52016Social Media Mining for Toxicovigilance: Automatic Monitoring of Prescription Medication Abuse from Twitter. (2016). Gonzalez, Graciela ; Malone, Dan ; Smith, Karen ; Scotch, Matthew ; Ginn, Rachel ; Oconnor, Karen ; Sarker, Abeed . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:3:d:10.1007_s40264-015-0379-4.

Full description at Econpapers || Download paper

6
62017Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase®. (2017). Fransson, Jonas ; Noren, Niklas G ; Chandler, Rebecca E ; Juhlin, Kristina ; Edwards, Ralph I ; Caster, Ola. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:1:d:10.1007_s40264-016-0456-3.

Full description at Econpapers || Download paper

6
72016Patient-Reported Safety Information: A Renaissance of Pharmacovigilance?. (2016). Leufkens, Hubert ; Kant, Agnes ; Raine, June ; Harmark, Linda ; Moretti, Ugo ; Sarinic, Viola Macolic ; Edwards, Ralph I. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:10:d:10.1007_s40264-016-0441-x.

Full description at Econpapers || Download paper

6
82016The Impact of Experiencing Adverse Drug Reactions on the Patient’s Quality of Life: A Retrospective Cross-Sectional Study in the Netherlands. (2016). Puijenbroek, Eugene ; Taxis, Katja ; Hunsel, Florence ; Rolfes, Lean. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:8:d:10.1007_s40264-016-0422-0.

Full description at Econpapers || Download paper

5
92016Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBase®. (2016). Olsson, Sten ; Pal, Shanthi N ; Hoekman, Jarno ; Alexander, ; Bruin, Marieke L ; Ampadu, Haggar H ; Sartori, Daniele. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:4:d:10.1007_s40264-015-0387-4.

Full description at Econpapers || Download paper

5
102019Patient Registries: An Underused Resource for Medicines Evaluation. (2019). PEter, ; Kurz, Xavier ; Bahri, Priya ; Zondag, Daniel Nogueras ; Castillon, Mireia ; Plueschke, Kelly ; Olmo, Carla Alonso ; McGettigan, Patricia. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:11:d:10.1007_s40264-019-00848-9.

Full description at Econpapers || Download paper

5
112016Appropriate Polypharmacy and Medicine Safety: When Many is not Too Many. (2016). Ryan, Cristin ; Hughes, Carmel M ; Cadogan, Cathal A. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:2:d:10.1007_s40264-015-0378-5.

Full description at Econpapers || Download paper

5
122019Recommendations on the Use of Mobile Applications for the Collection and Communication of Pharmaceutical Product Safety Information: Lessons from IMI WEB-RADR. (2019). Eemeren, Raphael ; Maskell, Simon ; Lewis, David J ; Tregunno, Phil ; PEter, ; Harmark, Linda ; Gama, Sara ; Bodin-Parssinen, Stephanie ; Vries, Sieta T ; Antoni, ; Pierce, Carrie E ; Dasgupta, Nabarun ; Newbould, Victoria ; Ptaszynska-Neophytou, Alicia. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:4:d:10.1007_s40264-019-00813-6.

Full description at Econpapers || Download Sorting Through the Safety Data Haystack: Using Machine Learning to Identify Individual Case Safety Reports in Social-Digital Media. (2018). Fine, Jennifer ; Ramakrishnan, Cartic ; Nagarajan, Meenakshi ; Meireis, Shawman ; Dorrell, Darren ; Hudson, Zoe ; Perera, Sujan ; Comfort, Shaun. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:6:d:10.1007_s40264-018-0641-7.

Full description at Econpapers || Download paper

4
142016Sequence Symmetry Analysis as a Signal Detection Tool for Potential Heart Failure Adverse Events in an Administrative Claims Database. (2016). Pratt, Nicole L ; Roughead, Elizabeth E ; Ellett, Lisa Kalisch ; Wahab, Izyan A. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:4:d:10.1007_s40264-015-0391-8.

Full description at Econpapers || Download paper

4
152019Detecting Adverse Drug Events with Rapidly Trained Classification Models. (2019). Patterson, Olga V ; Duvall, Scott L ; Alba, Patrick R ; Peterson, Kelly S ; Chapman, Alec B. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:1:d:10.1007_s40264-018-0763-y.

Full description at Econpapers || Download paper

4
162016Patient Reporting of Adverse Drug Reactions: An International Survey of National Competent Authorities’ Views and Needs. (2016). Matos, Cristiano ; Hunsel, Florence ; Harmark, Linda. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:11:d:10.1007_s40264-016-0453-6.

Full description at Econpapers || Download paper

4
172019Overview of the First Natural Language Processing Challenge for Extracting Medication, Indication, and Adverse Drug Events from Electronic Health Record Notes (MADE 1.0). (2019). Yu, Hong ; Liu, Weisong ; Jagannatha, Abhyuday. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:1:d:10.1007_s40264-018-0762-z.

Full description at Econpapers || Download paper

4
182018Coronary Events After Dispensing of Ibuprofen: A Propensity Score-Matched Cohort Study Versus Paracetamol in the French Nationwide Claims Database Sample. (2018). Moore, Nicholas ; Blin, Patrick ; Droz, Cecile ; Lassalle, Regis ; Abouelfath, Abdelilah ; Duong, Mai. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:11:d:10.1007_s40264-018-0686-7.

Full description at Econpapers || Download paper

4
192016The Patient’s Voice in Pharmacovigilance: Pragmatic Approaches to Building a Patient-Centric Drug Safety Organization. (2016). Smith, Meredith Y ; Benattia, Isma . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:9:d:10.1007_s40264-016-0426-9.

Full description at Econpapers || Download paper

4
202017Factors Influencing the Use of a Mobile App for Reporting Adverse Drug Reactions and Receiving Safety Information: A Qualitative Study. (2017). , Peter ; PEter, ; Ruiz, Carmen Lasheras ; Houez, Franois ; Sutcliffe, Alastair ; Wong, Lisa ; Vries, Sieta T. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:5:d:10.1007_s40264-016-0494-x.

Full description at Econpapers || Download paper

4
212019MADEx: A System for Detecting Medications, Adverse Drug Events, and Their Relations from Clinical Notes. (2019). Wu, Yonghui ; Hogan, William R ; Gong, Yan ; Bian, Jiang ; Yang, XI. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:1:d:10.1007_s40264-018-0761-0.

Full description at Econpapers || Download paper

4
222016Social Media Listening for Routine Post-Marketing Safety Surveillance. (2016). Thomas, Michele ; Burstein, Phil J ; Powell, Gregory E ; Brownstein, John S ; Painter, Jeffery L ; Dasgupta, Nabarun ; Rodriguez, Harold W ; Pierce, Carrie E ; Bell, Heidi G ; Menius, Alan J ; Freifeld, Clark C ; Blowers, James ; Reblin, Tjark ; Seifert, Harry A. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:5:d:10.1007_s40264-015-0385-6.

Full description at Econpapers || Download paper<

4
232019Adverse Drug Event Detection from Electronic Health Records Using Hierarchical Recurrent Neural Networks with Dual-Level Embedding. (2019). Kong, Xiangnan ; Rundensteiner, Elke A ; Sen, Cansu ; Kakar, Tabassum ; Qin, Xiao ; Wunnava, Susmitha. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:1:d:10.1007_s40264-018-0765-9.

Full description at Econpapers || Download paper

4
242017Patient Reporting in the EU: Analysis of EudraVigilance Data. (2017). Arlett, Peter ; Genov, Georgy ; Haerry, David ; Houez, Francois ; Slattery, Jim ; Candore, Gianmario ; Banovac, Marin . In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:7:d:10.1007_s40264-017-0534-1.

Full description at Econpapers || Download paper

4
252017An Algorithm to Identify Generic Drugs in the FDA Adverse Event Reporting System. (2017). Singh, Sonal ; Segal, Jodi B ; Marimuthu, Sathiya Priya ; Iyer, Geetha . In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:9:d:10.1007_s40264-017-0550-1.

Full description at Econpapers || Download paper

3
262019The Role of European Healthcare Databases for Post-Marketing Drug Effectiveness, Safety and Value Evaluation: Where Does Italy Stand?. (2019). Mugelli, Alessandro ; Clavenna, Antonio ; Corrao, Giovanni ; Moretti, Ugo ; Carnovale, Carla ; Mantovani, Lorenzo ; Lucenteforte, Ersilia ; Capuano, Annalisa ; Vannacci, Alfredo ; Leoni, Olivia ; Cantarutti, Anna ; Traversa, Giuseppe ; Leone, Roberto ; Beghi, Ettore ; Tettamanti, Mauro ; Lapi, Francesco ; Barone-Adesi, Francesco ; Sultana, Janet ; Kirchmayer, Ursula ; Gini, Rosa ; Rea, Federico ; Ingrasciotta, Ylenia ; Trifiro, Gianluca ; Rafaniello, Concita ; Franchi, Matteo ; Poluzzi, Elisabetta ; Ferrajolo, Carmen ; Naldi, Luigi ; Dellagiovanna, Mirosa. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:3:d:10.1007_s40264-018-073
272018Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the Literature. (2018). Pers, Yves-Marie ; Jorgensen, Christian ; Vernhet, Helene ; Roubille, Franois ; Chatre, Clotilde. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:10:d:10.1007_s40264-018-0689-4.

Full description at Econpapers || Download paper

3
282018Assessment of the Utility of Social Media for Broad-Ranging Statistical Signal Detection in Pharmacovigilance: Results from the WEB-RADR Project. (2018). Vroman, Benoit ; Tcherny-Lessenot, Stephanie ; Noren, Niklas G ; Maskell, Simon ; Lerch, Magnus ; Kurzinger, Marie-Laure ; Dietrich, Juergen ; Caster, Ola ; Stekelenborg, John ; Wisniewski, Antoni. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:12:d:10.1007_s40264-018-0699-2.

Full description at Econpapers || Download Communication on Safety of Medicines in Europe: Current Practices and General Practitioners’ Awareness and Preferences. (2017). Andri, Adriana ; Ipi, Ivana ; Montero, Dolores ; Coleman, Anna Marie ; Baldelli, Ilaria ; Cupelli, Amelia ; PEter, ; Vries, Sieta T ; Denig, Petra ; Ahlqvist-Rastad, Jane ; Wennberg, Annika . In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:8:d:10.1007_s40264-017-0535-0.

Full description at Econpapers || Download paper

3
302018From Big Data to Smart Data for Pharmacovigilance: The Role of Healthcare Databases and Other Emerging Sources. (2018). Bate, Andrew ; Sultana, Janet ; Trifiro, Gianluca. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:2:d:10.1007_s40264-017-0592-4.

Full description at Econpapers || Download paper

3
312016Performance of Stratified and Subgrouped Disproportionality Analyses in Spontaneous Databases. (2016). Arani, Ramin ; Wisniewski, Antoni ; Quarcoo, Naashika ; Juhlin, Kristina ; Candore, Gianmario ; Seabroke, Suzie ; Tregunno, Philip ; Painter, Jeffery ; Slattery, Jim ; Noren, Niklas G. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:4:d:10.1007_s40264-015-0388-3.

Full description at Econpapers || Download paper

3
322019Enabling Data-Driven Clinical Quality Assurance: Predicting Adverse Event Reporting in Clinical Trials Using Machine Learning. (2019). Popko, Leszek ; Bowling, Rich ; Koneswarakantha, Bjorn ; Barmaz, Yves ; Menard, Timothe. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:9:d:10.1007_s40264-019-00831-4.

Full description at Econpapers || Download paper

3
332017Adverse Drug Reaction-Related Hospitalizations in Elderly Australians: A Prospective Cross-Sectional Study in Two Tasmanian Hospitals. (2017). Bereznicki, Luke R ; Connolly, Michael ; Peterson, Gregory M ; Curtain, Colin ; Chalmers, Leanne ; Nair, Nibu Parameswaran . In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:7:d:10.1007_s40264-017-0528-z.

Full description at Econpapers || Download paper

3
342019The Role of European Patient Organizations in Pharmacovigilance. (2019). Hunsel, Florence ; Weits, Gerda ; Matos, Cristiano. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:4:d:10.1007_s40264-018-0748-x.

Full description at Econpapers || Download paper

3
352017Pharmaceutical Benefit–Risk Communication Tools: A Review of the Literature. (2017). Bouder, Frederic ; Way, Dominic ; Blazsin, Hortense ; Lofstedt, Ragnar. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:1:d:10.1007_s40264-016-0466-1.

Full description at Econpapers || Download paper

3
362016National ADR Monitoring System in China. (2016). Ye, Xiaofei ; Hou, Yongfang ; Li, Xinling ; Wu, Guizhi . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:11:d:10.1007_s40264-016-0446-5.

Full description at Econpapers || Download paper

3
372019Artificial Intelligence and the Future of the Drug Safety Professional. (2019). Widdowson, Mark ; Abatemarco, Danielle ; Mockute, Ruta ; Tetarenko, Niki ; Assuncao, Bruno ; Mingle, Edward ; Cicirello, Salvatore ; Danysz, Karolina ; Desai, Sameen. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:4:d:10.1007_s40264-018-0746-z.

Full description at Econpapers || Download paper

3
382020Prevalence and Nature of Medication Errors and Medication-Related Harm Following Discharge from Hospital to Community Settings: A Systematic Review. (2020). Keers, Richard N ; Steinke, Douglas ; Alqenae, Fatema A. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:6:d:10.1007_s40264-020-00918-3.

Full description at Econpapers || Download paper

3
392019Evaluation of Postmarketing Reports from Industry-Sponsored Programs in Drug Safety Surveillance. (2019). Dal, Gerald J ; Wu, Eileen ; Muoz, Monica A ; Kortepeter, Cindy M ; Kalra, Dipti ; Harinstein, Lisa. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:5:d:10.1007_s40264-018-0759-7.

Full description at Econpapers || Download paper

3
402020Follow-Up on the Use of Machine Learning in Clinical Quality Assurance: Can We Detect Adverse Event Under-Reporting in Oncology Trials?. (2020). Bowling, Rich ; Popko, Leszek ; Barmaz, Yves ; Rolo, Donato ; Koneswarakantha, Bjorn ; Menard, Timothe. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:3:d:10.1007_s40264-019-00894-3.

Full description at Econpapers || Download paper

3
412016Medication Errors: New EU Good Practice Guide on Risk Minimisation and Error Prevention. (2016). Newbould, Victoria ; Goedecke, Thomas ; Ord, Kathryn ; Arlett, Peter ; Brosch, Sabine. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:6:d:10.1007_s40264-016-0410-4.

Full description at Econpapers || Download paper

3
422016Adverse-Drug-Reaction-Related Hospitalisations in Developed and Developing Countries: A Review of Prevalence and Contributing Factors. (2016). Curtain, Colin M ; Angamo, Mulugeta Tarekegn ; Ke, LU ; Chalmers, Leanne. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:9:d:10.1007_s40264-016-0444-7.

Full description at Econpapers || Download paper

3
432018All-Cause and Drug-Related Medical Events Associated with Overuse of Gabapentin and/or Opioid Medications: A Retrospective Cohort Analysis of a Commercially Insured US Population. (2018). Sclar, David A ; Fairman, Kathleen A ; Peckham, Alyssa M. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:2:d:10.1007_s40264-017-0595-1.

Full description at Econpapers || Download paper

3
442020Development and First Use of the Patient’s Qualitative Assessment of Treatment (PQAT) Questionnaire in Type 2 Diabetes Mellitus to Explore Individualised Benefit–Harm of Drugs Received During Clinical. (2020). de Climens, Aude Roborel ; Nguyen-Pascal, My-Lien ; Burrows, Kate ; Brun-Strang, Catherine ; Findley, Amy ; Reaney, Matthew ; Gater, Adam. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:2:d:10.1007_s40264-019-00877-4.

Full description at Econpapers || Download

3
452017Causality Assessment in Pharmacovigilance: Still a Challenge. (2017). Edwards, Ralph I. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:5:d:10.1007_s40264-017-0509-2.

Full description at Econpapers || Download paper

3
462016A Survey of Adverse Event Reporting Practices Among US Healthcare Professionals. (2016). Felix, Thomas ; Brown, Carrie A ; Stergiopoulos, Stella ; Getz, Kenneth A ; Grampp, Gustavo . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:11:d:10.1007_s40264-016-0455-4.

Full description at Econpapers || Download paper

3
472018The RIMES Statement: A Checklist to Assess the Quality of Studies Evaluating Risk Minimization Programs for Medicinal Products. (2018). Morrato, Elaine H ; Freeman, Emily ; Frise, Sarah ; PEter, ; Bahri, Priya ; Russell, Andrea ; Smith, Meredith Y. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:4:d:10.1007_s40264-017-0619-x.

Full description at Econpapers || Download paper

2
482016Drug Interactions of Direct-Acting Oral Anticoagulants. (2016). Howes, Laurence Guy ; Fitzgerald, John Leonard . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:9:d:10.1007_s40264-016-0443-8.

Full description at Econpapers || Download paper

2
492016Completeness of Spontaneous Adverse Drug Reaction Reports Sent by General Practitioners to a Regional Pharmacovigilance Centre: A Descriptive Study. (2016). Montastruc, Franois ; Rousseau, Vanessa ; Bondon-Guitton, Emmanuelle ; Mege, Mathilde ; Jacquot, Julien ; Durrieu, Genevieve. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:12:d:10.1007_s40264-016-0463-4.

Full description at Econpapers || Download paper

2
502017Sensitivity of the UK Clinical Practice Research Datalink to Detect Neurodevelopmental Effects of Medicine Exposure in Utero: Comparative Analysis of an Antiepileptic Drug-Exposed Cohort. (2017). Richardson, J L ; Smithson, W H ; Clayton-Smith, J ; Wood, A ; Yates, L M ; Snowball, J ; Bromley, R ; McGrogan, A ; Baker, G A ; Charlton, R A ; McHugh, N. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:5:d:10.1007_s40264-017-0506-5.

Full description at Econpapers || Download

50 most relevant documents in this series (papers most cited in the last two years)
#YearTitleCited
12017Natural Language Processing for EHR-Based Pharmacovigilance: A Structured Review. (2017). Starren, Justin ; Carson, Matthew B ; Jonnalagadda, Siddhartha R ; Berendsen, Mark A ; Zeng, Zexian ; Herr, Timothy M ; Thompson, William K ; Luo, Yuan. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:11:d:10.1007_s40264-017-0558-6.

Full description at Econpapers || Download paper

4
22019Overview of the First Natural Language Processing Challenge for Extracting Medication, Indication, and Adverse Drug Events from Electronic Health Record Notes (MADE 1.0). (2019). Yu, Hong ; Liu, Weisong ; Jagannatha, Abhyuday. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:1:d:10.1007_s40264-018-0762-z.

Full description at Econpapers || Download paper

3
32020Development and First Use of the Patient’s Qualitative Assessment of Treatment (PQAT) Questionnaire in Type 2 Diabetes Mellitus to Explore Individualised Benefit–Harm of Drugs Received During Clinical. (2020). de Climens, Aude Roborel ; Nguyen-Pascal, My-Lien ; Burrows, Kate ; Brun-Strang, Catherine ; Findley, Amy ; Reaney, Matthew ; Gater, Adam. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:2:d:10.1007_s40264-019-00877-4.

Full description at Econpapers || Download

3
42016Appropriate Polypharmacy and Medicine Safety: When Many is not Too Many. (2016). Ryan, Cristin ; Hughes, Carmel M ; Cadogan, Cathal A. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:2:d:10.1007_s40264-015-0378-5.

Full description at Econpapers || Download paper

3
52018Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre. (2018). Hunsel, Florence ; Star, Kristina ; Zekarias, Alem ; Grundmark, Birgitta ; Harmark, Linda ; Taavola, Henric ; Chandler, Rebecca E ; Watson, Sarah. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:2:d:10.1007_s40264-017-0594-2.

Full description at Econpapers || Download paper

3
62020Follow-Up on the Use of Machine Learning in Clinical Quality Assurance: Can We Detect Adverse Event Under-Reporting in Oncology Trials?. (2020). Bowling, Rich ; Popko, Leszek ; Barmaz, Yves ; Rolo, Donato ; Koneswarakantha, Bjorn ; Menard, Timothe. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:3:d:10.1007_s40264-019-00894-3.

Full description at Econpapers || Download paper

3
72020Prevalence and Nature of Medication Errors and Medication-Related Harm Following Discharge from Hospital to Community Settings: A Systematic Review. (2020). Keers, Richard N ; Steinke, Douglas ; Alqenae, Fatema A. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:6:d:10.1007_s40264-020-00918-3.

Full description at Econpapers || Download paper

3
82017Patient Reporting in the EU: Analysis of EudraVigilance Data. (2017). Arlett, Peter ; Genov, Georgy ; Haerry, David ; Houez, Francois ; Slattery, Jim ; Candore, Gianmario ; Banovac, Marin . In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:7:d:10.1007_s40264-017-0534-1.

Full description at Econpapers || Download paper

3
92018Sorting Through the Safety Data Haystack: Using Machine Learning to Identify Individual Case Safety Reports in Social-Digital Media. (2018). Fine, Jennifer ; Ramakrishnan, Cartic ; Nagarajan, Meenakshi ; Meireis, Shawman ; Dorrell, Darren ; Hudson, Zoe ; Perera, Sujan ; Comfort, Shaun. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:6:d:10.1007_s40264-018-0641-7.

Full description at Econpapers || Download paper

3
102019Artificial Intelligence and the Future of the Drug Safety Professional. (2019). Widdowson, Mark ; Abatemarco, Danielle ; Mockute, Ruta ; Tetarenko, Niki ; Assuncao, Bruno ; Mingle, Edward ; Cicirello, Salvatore ; Danysz, Karolina ; Desai, Sameen. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:4:d:10.1007_s40264-018-0746-z.

Full description at Econpapers || Download paper

3
112019A Machine-Learning Algorithm to Optimise Automated Adverse Drug Reaction Detection from Clinical Coding. (2019). Frauman, Albert ; Aminian, Parnaz ; Keith, Claire ; Liew, David ; McMaster, Christopher. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:6:d:10.1007_s40264-018-00794-y.

Full description at Econpapers || Download paper

2
122019Aim and Design of pREGnant, the Dutch Pregnancy Drug Register. (2019). Puijenbroek, Eugene ; Roeleveld, Nel ; Kant, Agnes ; Winkel, Bernke ; Vorstenbosch, Saskia. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:1:d:10.1007_s40264-018-0722-7.

Full description at Econpapers || Download paper

2
132018Time Series Disturbance Detection for Hypothesis-Free Signal Detection in Longitudinal Observational Databases. (2018). Bate, Andrew ; Hauben, Manfred ; Whalen, ED. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:6:d:10.1007_s40264-018-0640-8.

Full description at Econpapers || Download paper

2
142020Sex Differences in Reported Adverse Drug Reactions to COVID-19 Drugs in a Global Database of Individual Case Safety Reports. (2020). Grundmark, Birgitta ; Vidlin, Sara Hedfors ; Watson, Sarah ; Zekarias, Alem. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:12:d:10.1007_s40264-020-01000-8.

Full description at Econpapers || Download paper

2
152017Evaluation of Facebook and Twitter Monitoring to Detect Safety Signals for Medical Products: An Analysis of Recent FDA Safety Alerts. (2017). Brownstein, John S ; Freifeld, Clark C ; Le, Hoa ; Rodriguez, Harold W ; Proestel, Scott ; Pamer, Carol ; Bouri, Khaled ; Pierce, Carrie E ; Dasgupta, Nabarun ; Edwards, Ralph I ; Walderhaug, Mark. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:4:d:10.1007_s40264-016-0491-0.

Full description at Econpapers || Download paper

2
162019Detecting Adverse Drug Events with Rapidly Trained Classification Models. (2019). Patterson, Olga V ; Duvall, Scott L ; Alba, Patrick R ; Peterson, Kelly S ; Chapman, Alec B. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:1:d:10.1007_s40264-018-0763-y.

Full description at Econpapers || Download paper

2
172017Causality Assessment in Pharmacovigilance: Still a Challenge. (2017). Edwards, Ralph I. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:5:d:10.1007_s40264-017-0509-2.

Full description at Econpapers || Download paper

2
182017Adverse Drug Reaction-Related Hospitalizations in Elderly Australians: A Prospective Cross-Sectional Study in Two Tasmanian Hospitals. (2017). Bereznicki, Luke R ; Connolly, Michael ; Peterson, Gregory M ; Curtain, Colin ; Chalmers, Leanne ; Nair, Nibu Parameswaran . In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:7:d:10.1007_s40264-017-0528-z.

Full description at Econpapers || Download paper

2
192017Sensitivity of the UK Clinical Practice Research Datalink to Detect Neurodevelopmental Effects of Medicine Exposure in Utero: Comparative Analysis of an Antiepileptic Drug-Exposed Cohort. (2017). Richardson, J L ; Smithson, W H ; Clayton-Smith, J ; Wood, A ; Yates, L M ; Snowball, J ; Bromley, R ; McGrogan, A ; Baker, G A ; Charlton, R A ; McHugh, N. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:5:d:10.1007_s40264-017-0506-5.

Full description at Econpapers || Download Validating Claims-Based Algorithms Determining Pregnancy Outcomes and Gestational Age Using a Linked Claims-Electronic Medical Record Database. (2021). Munoz, Flor M ; Eckert, Linda O ; Burrell, Timothy A ; Sheng, Minya ; Hobbi, Shayan ; Fingar, Kathryn ; Wong, Hui Lee ; Moll, Keran ; Anderson, Steven ; Shoaibi, Azadeh ; Baer, Bethany. In: Drug Safety. RePEc:spr:drugsa:v:44:y:2021:i:11:d:10.1007_s40264-021-01113-8.

Full description at Econpapers || Download paper<

2
212017Communication on Safety of Medicines in Europe: Current Practices and General Practitioners’ Awareness and Preferences. (2017). Andri, Adriana ; Ipi, Ivana ; Montero, Dolores ; Coleman, Anna Marie ; Baldelli, Ilaria ; Cupelli, Amelia ; PEter, ; Vries, Sieta T ; Denig, Petra ; Ahlqvist-Rastad, Jane ; Wennberg, Annika . In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:8:d:10.1007_s40264-017-0535-0.

Full description at Econpapers || Download paper

2
222018EudraVigilance Medicines Safety Database: Publicly Accessible Data for Research and Public Health Protection. (2018). Domergue, Francois ; Candore, Gianmario ; Kurz, Xavier ; Dogne, Jean-Michel ; Haren, Anja ; Slattery, Jim ; Brosch, Sabine ; Postigo, Rodrigo ; Arlett, Peter. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:7:d:10.1007_s40264-018-0647-1.

Full description at Econpapers || Download paper

2
232020Assessing the Safety of COVID-19 Vaccines: A Primer. (2020). Petousis-Harris, Helen. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:12:d:10.1007_s40264-020-01002-6.

Full description at Econpapers || Download paper

2
242019Correction to: A Machine-Learning Algorithm to Optimise Automated Adverse Drug Reaction Detection from Clinical Coding. (2019). Frauman, Albert ; Aminian, Parnaz ; Keith, Claire ; Liew, David ; McMaster, Christopher. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:6:d:10.1007_s40264-019-00820-7.

Full description at Econpapers || Download paper

2
252018Treatment of Medication-Related Osteonecrosis of the Jaw and its Impact on a Patient’s Quality of Life: A Single-Center, 10-Year Experience from Southern Italy. (2018). Marciano, Antonia ; Sultana, Janet ; Giorgianni, Francesco ; lo Presti, Loredana ; Peditto, Matteo ; Trifiro, Gianluca ; Oteri, Giacomo. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:1:d:10.1007_s40264-017-0582-6.

Full description at Econpapers || Download paper

2
262019The Role of European Patient Organizations in Pharmacovigilance. (2019). Hunsel, Florence ; Weits, Gerda ; Matos, Cristiano. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:4:d:10.1007_s40264-018-0748-x.

Full description at Econpapers || Download paper

2
272017Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase®. (2017). Fransson, Jonas ; Noren, Niklas G ; Chandler, Rebecca E ; Juhlin, Kristina ; Edwards, Ralph I ; Caster, Ola. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:1:d:10.1007_s40264-016-0456-3.

Full description at Econpapers || Download paper

2
282016Social Media Mining for Toxicovigilance: Automatic Monitoring of Prescription Medication Abuse from Twitter. (2016). Gonzalez, Graciela ; Malone, Dan ; Smith, Karen ; Scotch, Matthew ; Ginn, Rachel ; Oconnor, Karen ; Sarker, Abeed . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:3:d:10.1007_s40264-015-0379-4.

Full description at Econpapers || Download paper

2
292019Patient Registries: An Underused Resource for Medicines Evaluation. (2019). PEter, ; Kurz, Xavier ; Bahri, Priya ; Zondag, Daniel Nogueras ; Castillon, Mireia ; Plueschke, Kelly ; Olmo, Carla Alonso ; McGettigan, Patricia. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:11:d:10.1007_s40264-019-00848-9.

Full description at Econpapers || Download paper

2
302019Enabling Data-Driven Clinical Quality Assurance: Predicting Adverse Event Reporting in Clinical Trials Using Machine Learning. (2019). Popko, Leszek ; Bowling, Rich ; Koneswarakantha, Bjorn ; Barmaz, Yves ; Menard, Timothe. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:9:d:10.1007_s40264-019-00831-4.

Full description at Econpapers || Download paper

2
312019MADEx: A System for Detecting Medications, Adverse Drug Events, and Their Relations from Clinical Notes. (2019). Wu, Yonghui ; Hogan, William R ; Gong, Yan ; Bian, Jiang ; Yang, XI. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:1:d:10.1007_s40264-018-0761-0.

Full description at Econpapers || Download paper

2
322019Adverse Drug Event Detection from Electronic Health Records Using Hierarchical Recurrent Neural Networks with Dual-Level Embedding. (2019). Kong, Xiangnan ; Rundensteiner, Elke A ; Sen, Cansu ; Kakar, Tabassum ; Qin, Xiao ; Wunnava, Susmitha. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:1:d:10.1007_s40264-018-0765-9.

Full description at Econpapers || Download paper

2
332016Patient-Reported Safety Information: A Renaissance of Pharmacovigilance?. (2016). Leufkens, Hubert ; Kant, Agnes ; Raine, June ; Harmark, Linda ; Moretti, Ugo ; Sarinic, Viola Macolic ; Edwards, Ralph I. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:10:d:10.1007_s40264-016-0441-x.

Full description at Econpapers || Download paper

2
342016The Patient’s Voice in Pharmacovigilance: Pragmatic Approaches to Building a Patient-Centric Drug Safety Organization. (2016). Smith, Meredith Y ; Benattia, Isma . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:9:d:10.1007_s40264-016-0426-9.

Full description at Econpapers || Download paper

2
352016Completeness of Spontaneous Adverse Drug Reaction Reports Sent by General Practitioners to a Regional Pharmacovigilance Centre: A Descriptive Study. (2016). Montastruc, Franois ; Rousseau, Vanessa ; Bondon-Guitton, Emmanuelle ; Mege, Mathilde ; Jacquot, Julien ; Durrieu, Genevieve. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:12:d:10.1007_s40264-016-0463-4.

Full description at Econpapers || Download paper

2
362020Risk Factor Considerations in Statistical Signal Detection: Using Subgroup Disproportionality to Uncover Risk Groups for Adverse Drug Reactions in VigiBase. (2020). Noren, Niklas G ; Chandler, Rebecca ; Aoki, Yasunori ; Taavola, Henric ; Sandberg, Lovisa. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:10:d:10.1007_s40264-020-00957-w.

Full description at Econpapers || Download paper

2
372019The Role of European Healthcare Databases for Post-Marketing Drug Effectiveness, Safety and Value Evaluation: Where Does Italy Stand?. (2019). Mugelli, Alessandro ; Clavenna, Antonio ; Corrao, Giovanni ; Moretti, Ugo ; Carnovale, Carla ; Mantovani, Lorenzo ; Lucenteforte, Ersilia ; Capuano, Annalisa ; Vannacci, Alfredo ; Leoni, Olivia ; Cantarutti, Anna ; Traversa, Giuseppe ; Leone, Roberto ; Beghi, Ettore ; Tettamanti, Mauro ; Lapi, Francesco ; Barone-Adesi, Francesco ; Sultana, Janet ; Kirchmayer, Ursula ; Gini, Rosa ; Rea, Federico ; Ingrasciotta, Ylenia ; Trifiro, Gianluca ; Rafaniello, Concita ; Franchi, Matteo ; Poluzzi, Elisabetta ; Ferrajolo, Carmen ; Naldi, Luigi ; Dellagiovanna, Mirosa. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:3:d:10.1007_s40264-018-072
382019Recommendations on the Use of Mobile Applications for the Collection and Communication of Pharmaceutical Product Safety Information: Lessons from IMI WEB-RADR. (2019). Eemeren, Raphael ; Maskell, Simon ; Lewis, David J ; Tregunno, Phil ; PEter, ; Harmark, Linda ; Gama, Sara ; Bodin-Parssinen, Stephanie ; Vries, Sieta T ; Antoni, ; Pierce, Carrie E ; Dasgupta, Nabarun ; Newbould, Victoria ; Ptaszynska-Neophytou, Alicia. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:4:d:10.1007_s40264-019-00813-6.

Full description at Econpapers || Download A Survey of Adverse Event Reporting Practices Among US Healthcare Professionals. (2016). Felix, Thomas ; Brown, Carrie A ; Stergiopoulos, Stella ; Getz, Kenneth A ; Grampp, Gustavo . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:11:d:10.1007_s40264-016-0455-4.

Full description at Econpapers || Download paper

2
402018All-Cause and Drug-Related Medical Events Associated with Overuse of Gabapentin and/or Opioid Medications: A Retrospective Cohort Analysis of a Commercially Insured US Population. (2018). Sclar, David A ; Fairman, Kathleen A ; Peckham, Alyssa M. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:2:d:10.1007_s40264-017-0595-1.

Full description at Econpapers || Download paper

2
412021Incidence Rates of Autoimmune Diseases in European Healthcare Databases: A Contribution of the ADVANCE Project. (2021). Huerta, Consuelo ; Gini, Rosa ; Kahlert, Johnny ; Emborg, Hanne-Dorthe ; Titievsky, Lina ; Picelli, Gino ; Weibel, Daniel ; van der Aa, Lieke ; Villa, Marco ; Dodd, Caitlin ; Roberto, Giuseppe ; Willame, Corinne ; Lusignan, Simon ; McGee, Chris ; Martin-Merino, Elisa. In: Drug Safety. RePEc:spr:drugsa:v:44:y:2021:i:3:d:10.1007_s40264-020-01031-1.

Full description at Econpapers || Download Spontaneous Reporting to Regulatory Authorities of Suspected Adverse Drug Reactions to COVID-19 Vaccines Over Time: The Effect of Publicity. (2022). Aronson, Jeffrey K ; Anton, Christopher ; Stevens, Richard J ; Ferner, Robin E. In: Drug Safety. RePEc:spr:drugsa:v:45:y:2022:i:2:d:10.1007_s40264-021-01138-z.

Full description at Econpapers || Download paper

2
432020Comparative Assessment of the National Pharmacovigilance Systems in East Africa: Ethiopia, Kenya, Rwanda and Tanzania. (2020). Guantai, Anastasia ; Oluka, Margaret ; Kamuhabwa, Appolinary ; Makonnen, Eyasu ; Bienvenu, Emile ; Minzi, Omary ; Olsson, Sten ; Aklillu, Eleni ; Barry, Abbie ; Gurumurthy, Parthasarathi ; Puijenbroek, Eugene ; Bergman, Ulf. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:4:d:10.1007_s40264-019-00898-z.

Full description at Econpapers || Download

Citing documents used to compute impact factor: 21
YearTitle
2022Multi-criteria decision analysis for benefit-risk analysis by national regulatory authorities. (2022). Phillips, Lawrence ; Sharry, Patrick ; Chisholm, Orin. In: LSE Research Online Documents on Economics. RePEc:ehl:lserod:114407.

Full description at Econpapers || Download paper

2022Developing Strategic Recommendations for Implementing Smart Pumps in Advanced Healthcare Systems to Improve Intravenous Medication Safety. (2022). Franklin, Bryony Dean ; Patel, Arif ; Arenas-Lopez, Sara ; Howlett, Moninne ; Jones, Matthew D ; Sutherland, Adam. In: Drug Safety. RePEc:spr:drugsa:v:45:y:2022:i:8:d:10.1007_s40264-022-01203-1.

Full description at Econpapers || Download paper

2022.

Full description at Econpapers || Download paper

2022.

Full description at Econpapers || Download paper

2022Artificial Intelligence-Based Pharmacovigilance in the Setting of Limited Resources. (2022). Hao, Tianyong ; Li, Yong ; He, Yuejun ; Wu, GE ; Hong, NA ; Sun, Gang ; Hu, Jifa ; Liang, Likeng ; Gong, Mengchun ; Liu, LI. In: Drug Safety. RePEc:spr:drugsa:v:45:y:2022:i:5:d:10.1007_s40264-022-01170-7.

Full description at Econpapers || Download paper

2022Product-Service Systems for Circular Supply Chain Management: A Functional Approach. (2022). Haber, Nicolas ; Fargnoli, Mario. In: Sustainability. RePEc:gam:jsusta:v:14:y:2022:i:22:p:14953-:d:970370.

Full description at Econpapers || Download paper

2022Cannabinoid-Related Acute Pancreatitis: An Update from International Literature and Individual Case Safety Reports. (2022). Lapeyre-Mestre, Maryse ; Culetto, Adrian ; Buscail, Louis ; Azam, Camille. In: Drug Safety. RePEc:spr:drugsa:v:45:y:2022:i:3:d:10.1007_s40264-022-01146-7.

Full description at Econpapers || Download paper

2022Machine Learning in Causal Inference: Application in Pharmacovigilance. (2022). Luo, Yuan ; Jiang, Guoqian ; Deng, YU ; Li, Yikuan ; Wang, Hanyin ; Yu, Yue ; Zhao, Yiqing. In: Drug Safety. RePEc:spr:drugsa:v:45:y:2022:i:5:d:10.1007_s40264-022-01155-6.

Full description at Econpapers || Download paper

2022.

Full description at Econpapers || Download paper

2022Prevalence, Causes and Severity of Medication Administration Errors in the Neonatal Intensive Care Unit: A Systematic Review and Meta-Analysis. (2022). Shah, Noraida Mohamed ; Mohd, Nurul Ain ; Ali, Adliah Mhd ; Premakumar, Chandini Menon ; Basil, Josephine Henry. In: Drug Safety. RePEc:spr:drugsa:v:45:y:2022:i:12:d:10.1007_s40264-022-01236-6.

Full description at Econpapers || Download paper

2022.

Full description at Econpapers || Download paper

2022.

Full description at Econpapers || Download paper

2022.

Full description at Econpapers || Download paper

2022Patient-Reported Reasons for Switching or Discontinuing Statin Therapy: A Mixed Methods Study Using Social Media. (2022). Hernandez, Graciela Gonzalez ; Gross, Robert ; Hennessy, Sean ; Oconnor, Karen ; Weissenbacher, Davy ; Golder, SU. In: Drug Safety. RePEc:spr:drugsa:v:45:y:2022:i:9:d:10.1007_s40264-022-01212-0.

Full description at Econpapers || Download paper

2022.

Full description at Econpapers || Download paper

2022.

Full description at Econpapers || Download paper

2022Black Swan Events and Intelligent Automation for Routine Safety Surveillance. (2022). Bate, Andrew ; Kjoersvik, Oeystein. In: Drug Safety. RePEc:spr:drugsa:v:45:y:2022:i:5:d:10.1007_s40264-022-01169-0.

Full description at Econpapers || Download paper

2022.

Full description at Econpapers || Download paper

2022Visualizing the Knowledge Base and Research Hotspot of Public Health Emergency Management: A Science Mapping Analysis-Based Study. (2022). Wang, Han ; Lin, Xiaoping ; Chen, Kai ; Liu, Hui ; Huang, Rui ; Kong, Jie ; Qiang, Yujie. In: Sustainability. RePEc:gam:jsusta:v:14:y:2022:i:12:p:7389-:d:840678.

Full description at Econpapers || Download paper

2022.

Full description at Econpapers || Download paper

2022.

Full description at Econpapers || Download paper

Recent citations
Recent citations received in 2022
YearCiting document
2022Conundrum of Clinical QTc Monitoring. (2022). Malik, Marek. In: Drug Safety. RePEc:spr:drugsa:v:45:y:2022:i:10:d:10.1007_s40264-022-01229-5.

Full description at Econpapers || Download paper

2022Authors’ Response to Yoshihiro Noguchi’s Comment on: “A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)”. (2022). Boyce, Richard D ; Tan, Malinda S ; Horn, John ; Gomez-Lumbreras, Ainhoa ; Villa-Zapata, Lorenzo ; Malone, Daniel C. In: Drug Safety. RePEc:spr:drugsa:v:45:y:2022:i:12:d:10.1007_s40264-022-01239-3.

Full description at Econpapers || Download paper

2022Authors’ Reply to Noguchi’s comment on: “Drug-Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting. (2022). Alkabbani, Wajd ; Gamble, John-Michael. In: Drug Safety. RePEc:spr:drugsa:v:45:y:2022:i:7:d:10.1007_s40264-022-01192-1.

Full description at Econpapers || Download paper

Recent citations received in 2021
YearCiting document
2021.

Full description at Econpapers || Download paper

2021.

Full description at Econpapers || Download paper

2021The Effectiveness and Value of Written Medicine Information Across Asia and Africa: Systematic Review. (2021). Krska, Janet ; Corlett, Sarah A ; Nualdaisri, Pitchaya. In: Drug Safety. RePEc:spr:drugsa:v:44:y:2021:i:12:d:10.1007_s40264-021-01114-7.

Full description at Econpapers || Download paper

2021Authors’ Reply to Michael Auerbach’s Comment on: “Frequency and Associated Costs of Anaphylaxis- and Hypersensitivity-Related Adverse Events for Intravenous Iron Products in the USA: An Analysis Using. (2021). Numan, Syed ; Kaluza, Karolina ; Trumbo, Henry ; Goodnough, Lawrence T. In: Drug Safety. RePEc:spr:drugsa:v:44:y:2021:i:5:d:10.1007_s40264-021-01059-x.

Full description at Econpapers || Download paper

2021The Safety Profile of Upadacitinib in Patients with Rheumatoid Arthritis in Japan. (2021). Zhang, Ying ; Song, Yanna ; Harigai, Masayoshi ; Sasaki, Nobuhito ; Khan, Nasser ; Kameda, Hideto ; Tanaka, Yoshiya ; Yamaoka, Kunihiro ; Takeuchi, Tsutomu. In: Drug Safety. RePEc:spr:drugsa:v:44:y:2021:i:6:d:10.1007_s40264-021-01067-x.

Full description at Econpapers || Download paper

2021A Multi-modal Approach to Evaluate the Impact of Risk Evaluation and Mitigation Strategy (REMS) Programs. (2021). Manzo, Claudia ; Lacivita, Cynthia ; Toyserkani, Gita A ; Kesselheim, Aaron S ; Woloshin, Steven ; Chin, Kristyn ; Avorn, Jerry ; Feldman, William B ; Bykov, Katsiaryna ; Huybrechts, Krista F ; Mitra-Majumdar, Mayookha ; Gagne, Joshua J ; Sarpatwari, Ameet ; Dal, Gerald J ; Pinnow, Ellen ; Zhou, Esther H. In: Drug Safety. RePEc:spr:drugsa:v:44:y:2021:i:7:d:10.1007_s40264-021-01070-2.

Full description at Econpapers || Download Capturing Data in Rare Disease Registries to Support Regulatory Decision Making: A Survey Study Among Industry and Other Stakeholders. (2021). , Peter ; PEter, ; Hoes, Arno W ; McGettigan, Patricia ; Berg, Marijke H ; Vries, Sieta T ; Jonker, Carla J. In: Drug Safety. RePEc:spr:drugsa:v:44:y:2021:i:8:d:10.1007_s40264-021-01081-z.

Full description at Econpapers || Download paper

2021Authors’ Reply to Braillon and Martin’s Comment on “Proposals for Engaging Patients and Healthcare Professionals in Risk Minimisation from an Analysis of Stakeholder Input to the EU Valproate Assessme. (2021). , Sabine ; Dogne, Jean-Michel ; Inoubli, Adrien ; Morales, Daniel R ; Bahri, Priya. In: Drug Safety. RePEc:spr:drugsa:v:44:y:2021:i:9:d:10.1007_s40264-021-01096-6.

Full description at Econpapers || Download paper

Recent citations received in 2020
YearCiting document
2020Evaluation of a Web-Based, ‘Purchase Event’ Intensive Monitoring Method for Pharmacovigilance of Natural Health Products: Lessons and Insights from Development Work in New Zealand. (2020). Harrison-Woolrych, Mira ; Vohra, Sunita ; Harmark, Linda ; Dong, Christine Yang ; Sheridan, Jane L ; Barnes, Joanne. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:10:d:10.1007_s40264-020-00963-y.

Full description at Econpapers || Download paper

2020Real-World Data on Bleeding Risk and Anticoagulation in Patients with IPF Treated with Antifibrotics. (2020). Kalluri, Meena ; Bendstrup, Elisabeth. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:10:d:10.1007_s40264-020-00991-8.

Full description at Econpapers || Download paper

2020Benefit–Risk Assessment of Vaccines. Part I: A Systematic Review to Identify and Describe Studies About Quantitative Benefit–Risk Models Applied to Vaccines. (2020). Praet, Nicolas ; Begaud, Bernard ; Nachbaur, Gaelle ; Bauchau, Vincent ; Salvo, Francesco ; Bollaerts, Kaatje ; Arlegui, Hugo. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:11:d:10.1007_s40264-020-00984-7.

Full description at Econpapers || Download paper

2020Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance. (2020). Poluzzi, Elisabetta ; Diemberger, Igor ; Fusaroli, Michele ; Raschi, Emanuel. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:11:d:10.1007_s40264-020-00990-9.

Full description at Econpapers || Download paper

2020Liver Injury Associated with the Selective Progesterone Modulator Ulipristal. (2020). Bjornsson, Einar S. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:12:d:10.1007_s40264-020-01004-4.

Full description at Econpapers || Download paper

2020An Evaluation of Postmarketing Reports with an Outcome of Death in the US FDA Adverse Event Reporting System. (2020). Muoz, Monica A ; Dal, Gerald J ; Kortepeter, Cindy M ; Jones, Christopher S ; Marwitz, Kathryn. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:5:d:10.1007_s40264-020-00908-5.

Full description at Econpapers || Download paper

2020A New Drug–Drug Interaction Between Hydroxychloroquine and Metformin? A Signal Detection Study. (2020). Toutain, Pierre-Louis ; Montastruc, Jean-Louis. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:7:d:10.1007_s40264-020-00955-y.

Full description at Econpapers || Download paper

2020Lopinavir-Ritonavir in the Treatment of COVID-19: A Dynamic Systematic Benefit-Risk Assessment. (2020). Shakir, Saad ; Roy, Debabrata ; Dhanda, Sandeep ; Denyer, Jacqueline ; Evans, Alison ; Lane, Samantha ; Davies, Miranda ; Osborne, Vicki. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:8:d:10.1007_s40264-020-00966-9.

Full description at Econpapers || Download paper

2020Thromboembolism and Janus Kinase Inhibitors. (2020). Scott, David L ; Ibrahim, Fowzia. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:9:d:10.1007_s40264-020-00973-w.

Full description at Econpapers || Download paper

2020The Evolving Field of Risk Communication. (2020). Besley, John ; McComas, Katherine ; Balogway, Dominic. In: Risk Analysis. RePEc:wly:riskan:v:40:y:2020:i:s1:p:2240-2262.

Full description at Econpapers || Download paper

Recent citations received in 2019
YearCiting document
2019The Impact of Litigation-Associated Reports on Signal Identification in the US FDA’s Adverse Event Reporting System. (2019). Dal, Gerald J ; Muoz, Monica A. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:10:d:10.1007_s40264-019-00834-1.

Full description at Econpapers || Download paper

2019Cardiovascular Safety of Prucalopride in Patients with Chronic Constipation: A Multinational Population-Based Cohort Study. (2019). Harding, Abenah ; Andrews, Elizabeth B ; Garcia-Rodriguez, Luis ; Ziemiecki, Ryan ; Schink, Tania ; Robert, ; Ruigomez, Ana ; Cantero, Oscar F ; Plana, Estel ; Cainzos-Achirica, Miguel ; Odsbu, Ingvild ; Fortuny, Joan ; MacDonald, Thomas M ; Gilsenan, Alicia ; Linner, Love ; Karlsson, Par ; Kollhorst, Bianca. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:10:d:10.1007_s40264-019-00835-0.

Full description at Econpapers || Download Study Design and Cohort Comparability in a Study of Major Cardiovascular Events in New Users of Prucalopride Versus Polyethylene Glycol 3350. (2019). Kollhorst, Bianca ; Garcia-Rodriguez, Luis ; Andrews, Elizabeth B ; Robert, ; Ziemiecki, Ryan ; Cantero, Oscar F ; Schink, Tania ; Cainzos-Achirica, Miguel ; Ruigomez, Ana ; Gilsenan, Alicia ; Plana, Estel ; Fortuny, Joan ; MacDonald, Thomas M ; Linner, Love ; Karlsson, Par. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:10:d:10.1007_s40264-019-00836-z.

Full description at Econpapers || Download Comment on: “Patient Registries: An Underused Resource for Medicines Evaluation: Operational Proposals for Increasing the Use of Patient Registries in Regulatory Assessments”. (2019). Jandhyala, Ravi. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:12:d:10.1007_s40264-019-00862-x.

Full description at Econpapers || Download paper

2019Authors’ Reply to Ravi Jandhyala’s Comment on “Patient Registries: An Underused Resource for Medicines Evaluation: Operational Proposals for Increasing the Use of Patient Registries in Regulatory Asse. (2019). PEter, ; Kurz, Xavier ; Bahri, Priya ; Zondag, Daniel ; Castillon, Mireia ; Plueschke, Kelly ; Olmo, Carla Alonso ; McGettigan, Patricia. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:12:d:10.1007_s40264-019-00863-w.

Full description at Econpapers || Download Comparative Effectiveness and Safety of Direct Oral Anticoagulants: Overview of Systematic Reviews. (2019). de Ponti, Fabrizio ; Squizzato, Alessandro ; Gatti, Milo ; Bianchin, Matteo ; Raschi, Emanuel. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:12:d:10.1007_s40264-019-00866-7.

Full description at Econpapers || Download paper

2019Overview of the First Natural Language Processing Challenge for Extracting Medication, Indication, and Adverse Drug Events from Electronic Health Record Notes (MADE 1.0). (2019). Yu, Hong ; Liu, Weisong ; Jagannatha, Abhyuday. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:1:d:10.1007_s40264-018-0762-z.

Full description at Econpapers || Download paper

2019Towards Drug Safety Surveillance and Pharmacovigilance: Current Progress in Detecting Medication and Adverse Drug Events from Electronic Health Records. (2019). Yu, Hong ; Jagannatha, Abhyuday ; Liu, Feifan. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:1:d:10.1007_s40264-018-0766-8.

Full description at Econpapers || Download paper

2019Safety of Novel Targeted Therapies in Oncology. (2019). Curigliano, Giuseppe ; Shah, Rashmi R. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:2:d:10.1007_s40264-018-0770-z.

Full description at Econpapers || Download paper

2019Recommendations on the Use of Mobile Applications for the Collection and Communication of Pharmaceutical Product Safety Information: Lessons from IMI WEB-RADR. (2019). Eemeren, Raphael ; Maskell, Simon ; Lewis, David J ; Tregunno, Phil ; PEter, ; Harmark, Linda ; Gama, Sara ; Bodin-Parssinen, Stephanie ; Vries, Sieta T ; Antoni, ; Pierce, Carrie E ; Dasgupta, Nabarun ; Newbould, Victoria ; Ptaszynska-Neophytou, Alicia. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:4:d:10.1007_s40264-019-00813-6.

Full description at Econpapers || Download Building an Evidence Base on the Place of Industry-Sponsored Programs in Drug Safety Surveillance. (2019). Arlett, Peter. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:5:d:10.1007_s40264-018-00791-1.

Full description at Econpapers || Download paper

2019From Data Silos to Standardized, Linked, and FAIR Data for Pharmacovigilance: Current Advances and Challenges with Observational Healthcare Data. (2019). Koutkias, Vassilis. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:5:d:10.1007_s40264-018-00793-z.

Full description at Econpapers || Download paper

2019Authors’ reply to Schaffalitzky de Muckadell and colleague’s Comment on “Evaluation of the Reported Rates of Severe Hypersensitivity Reactions Associated with Ferric Carboxymaltose and Iron (III) Isom. (2019). Wohlfeil, Stefan ; Toussi, Massoud ; Bocuk, Derya ; Gohlke, Annegret ; Nathell, Lennart ; Ehlken, Birgit. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:5:d:10.1007_s40264-019-00815-4.

Full description at Econpapers || Download paper

2019Frailty and Drug Safety at Older Ages. (2019). Gulliford, Martin . In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:6:d:10.1007_s40264-019-00796-4.

Full description at Econpapers || Download paper

2019Inflammation, Monoclonal Antibodies and Depression: Joining the Dots. (2019). Hunt, David. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:7:d:10.1007_s40264-019-00819-0.

Full description at Econpapers || Download paper

2019A Profile of Adverse Drug Reactions of Atazanavir- and Lopinavir-Based Antiretroviral Regimens in Namibia. (2019). Rennie, Timothy William ; Adenuga, Babafunso Aderemi. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:7:d:10.1007_s40264-019-00832-3.

Full description at Econpapers || Download paper